569 related articles for article (PubMed ID: 18328306)
1. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
Chalmers JD; Singanayagam A; Hill AT
Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
[TBL] [Abstract][Full Text] [Related]
2. Prior statin use is associated with improved outcomes in community-acquired pneumonia.
Chalmers JD; Singanayagam A; Murray MP; Hill AT
Am J Med; 2008 Nov; 121(11):1002-1007.e1. PubMed ID: 18954848
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
[TBL] [Abstract][Full Text] [Related]
4. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
[TBL] [Abstract][Full Text] [Related]
5. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.
Hohenthal U; Hurme S; Helenius H; Heiro M; Meurman O; Nikoskelainen J; Kotilainen P
Clin Microbiol Infect; 2009 Nov; 15(11):1026-32. PubMed ID: 19548923
[TBL] [Abstract][Full Text] [Related]
6. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.
Chalmers JD; Singanayagam A; Hill AT
Thorax; 2008 Aug; 63(8):698-702. PubMed ID: 18492742
[TBL] [Abstract][Full Text] [Related]
7. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
Chalmers JD; Singanayagam A; Scally C; Hill AT
Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
[TBL] [Abstract][Full Text] [Related]
8. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS
J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.
Sierros V; Fleming R; Cascioli M; Brady T
Chron Respir Dis; 2009; 6(3):149-55. PubMed ID: 19643829
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein in acute myocardial infarction: association with heart failure.
Berton G; Cordiano R; Palmieri R; Pianca S; Pagliara V; Palatini P
Am Heart J; 2003 Jun; 145(6):1094-101. PubMed ID: 12796768
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
Kontou P; Kuti JL; Nicolau DP
Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
[TBL] [Abstract][Full Text] [Related]
15. [The influence of community-acquired pneumonia to the clinical course in COPD cases admitted to intensive care unit with acute respiratory failure].
Güngör G; Yazıcıoğlu Moçin O; Acartürk E; Başbuğ Y; Saltürk C; Yalçınsoy M; Karakurt Z
Tuberk Toraks; 2010; 58(4):408-17. PubMed ID: 21341118
[TBL] [Abstract][Full Text] [Related]
16. [C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia].
Bircan A; Kaya O; Gökirmak M; Oztürk O; Sahin U; Akkaya A
Tuberk Toraks; 2006; 54(1):22-9. PubMed ID: 16615014
[TBL] [Abstract][Full Text] [Related]
17. Severe community-acquired pneumonia: an Australian perspective.
Wilson PA; Ferguson J
Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
[TBL] [Abstract][Full Text] [Related]
18. Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia.
Singanayagam A; Chalmers JD; Hill AT
Eur Respir J; 2009 Oct; 34(4):932-9. PubMed ID: 19541709
[TBL] [Abstract][Full Text] [Related]
19. Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections.
Chen YH; Yao WZ; Gao JZ; Geng B; Wang PP; Tang CS
Respirology; 2009 Jul; 14(5):746-52. PubMed ID: 19659653
[TBL] [Abstract][Full Text] [Related]
20. Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit.
Gowardman J; Trent L
N Z Med J; 2000 May; 113(1109):161-4. PubMed ID: 10894342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
